Ebola is a very dangerous disease caused by a specific virus. It spreads through direct contact with the blood or body fluids of an infected person. It can cause severe bleeding and is often fatal.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Ebola disease is a rare but severe viral infection that is often fatal. It belongs to a group of illnesses called viral hemorrhagic fevers, which damage blood vessels and affect many organs at once. It usually begins suddenly with fever, exhaustion, muscle pain, headache and sore throat, followed by vomiting, diarrhea and abdominal pain. As it progresses, it can affect the kidneys and liver, and some people develop bleeding. The name hemorrhagic fever suggests that bleeding is the main feature, but bleeding is less common than people expect and tends to appear later in the illness. Dehydration and organ damage drive much of the danger. Across past outbreaks, about half of people with Ebola have died on average, with rates ranging from 25% to 90% depending on the virus, the outbreak and access to care. Several related viruses cause Ebola disease. The one usually called Ebola virus (the Zaire species) is the most familiar, and it is the only one with approved treatments and an approved vaccine. Sudan virus and Bundibugyo virus also cause outbreaks but have no approved treatment or vaccine yet.
Ebola viruses are thought to live naturally in fruit bats. An outbreak typically starts when a person handles the blood, organs or meat of an infected animal, such as a fruit bat, monkey, ape or forest antelope. Outbreaks have occurred mostly in Central and West Africa. From there, the virus spreads between people through direct contact, via broken skin or the lining of the eyes, nose or mouth, with the blood or body fluids (such as vomit, stool or urine) of someone who is sick with Ebola or has died from it. Clothing, bedding, needles and medical equipment soiled with those fluids can also carry it. Ebola does not spread through the air the way flu does, and a person who has been infected cannot pass it on before their symptoms start. The people most at risk are family members caring for a sick relative at home, health workers without strict infection control, and people who touch the body during traditional burials. The virus can also linger in the semen of men who have recovered, so sexual contact with a survivor is another route of spread.
Symptoms appear anywhere from 2 to 21 days after exposure, most often around 8 to 10 days. The early illness looks like many more common infections, including malaria, typhoid fever and other causes of fever, so the key question for a clinician is whether the person could have been exposed: recent time in an area with an active outbreak, or contact with someone who had Ebola or their body fluids. When exposure is possible, the diagnosis is confirmed with a blood test, usually RT-PCR (reverse transcriptase polymerase chain reaction), which detects the virus's genetic material. Because the virus may not show up in the blood until a few days after symptoms begin, an early negative test may need repeating. The person is kept in isolation while testing is underway, and samples are handled under strict laboratory safety rules. Testing for other causes such as malaria usually happens at the same time, since a person can have more than one infection.
Treatment takes place in a specialized unit where staff use protective equipment and the person is isolated. The foundation is intensive supportive care: replacing the large amounts of fluid and salts lost through vomiting and diarrhea, supporting blood pressure, giving oxygen, controlling fever and pain, and treating other infections such as malaria. This care improves survival whatever virus is involved, and it works best when it starts early. For infection with the Zaire species, two treatments approved by the US Food and Drug Administration add a direct attack on the virus. Both are monoclonal antibodies, laboratory-made immune proteins that latch onto the virus and help stop it from infecting cells. Inmazeb (a combination of three antibodies: atoltivimab, maftivimab and odesivimab) and Ebanga (ansuvimab) are each given as a single infusion into a vein and are approved for adults and children, including newborns of infected mothers. In the large trial that led to their approval, about one in three people treated with either antibody died within 28 days, compared with about one in two who received an older experimental antibody treatment. Results were better when treatment started soon after symptoms began. These antibodies are not proven against Sudan or Bundibugyo virus. For those infections, supportive care is the main treatment, and experimental products are studied in clinical trials during outbreaks. A vaccine, Ervebo, protects against the Zaire species for people 12 months and older. It is used as part of outbreak response and for health and laboratory workers who may be exposed. How long its protection lasts is not known, and it does not protect against the other Ebola viruses.
Ebola is a short, intense illness. People who survive often still have fever for several days and begin to improve around the end of the first week of symptoms, though regaining strength takes much longer. Once the virus is cleared from the blood, a person is no longer infectious through ordinary contact and does not need to stay isolated. Recovery often brings lasting problems that vary in timing and severity. Common ones include tiredness, headaches, muscle and joint pain, and eye and vision problems. Many survivors also face grief, anxiety and stigma in their communities. Follow-up care, including eye checks and emotional support, is part of recovery. The virus can persist for months in parts of the body that the immune system reaches less easily, such as the testicles, the inside of the eye and the brain. A return of illness without new exposure is rare but has happened. Sexual transmission through semen has been documented up to 15 months after recovery, so male survivors are advised to use condoms and safer sex practices until two semen tests in a row are negative, or for 12 months if testing is not available. The virus can also be present in breast milk and, in women infected during pregnancy, in the placenta and fetus, so pregnant and breastfeeding survivors need specialized follow-up.
If you have been in an area with an Ebola outbreak, or had contact with someone with Ebola or their body fluids, within the past 21 days and develop fever, severe headache, muscle pain, vomiting, diarrhea or unexplained bleeding or bruising, call a doctor or your local health department right away and tell them about the possible exposure. This allows testing and treatment to start quickly and lets staff prepare to protect others. If you have recovered from Ebola, contact your care team promptly about new eye pain, redness or changes in vision, or a return of fever, since these can signal problems that need specialist care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Ebola is like, what's helped you, or ask the community a question.